LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats-Reference-Cited by-同舟云学术

LmrBPP9: A synthetic bradykinin-potentiating peptide from Lachesis muta rhombeata venom that inhibits the angiotensin-converting enzyme activity in vitro and reduces the blood pressure of hypertensive rats

Published:2018-04 Issue: Volume:102 Page:1-7
ISSN:0196-9781
Container-title:Peptides
language:en
Short-container-title:Peptides

Author:

Pinheiro-Júnior Ernesto Lopes,Boldrini-França Johara,de Campos Araújo Luciana Mattoso Pires,Santos-Filho Norival Alves,Bendhack Lusiane Maria,Cilli Eduardo Maffud,Arantes Eliane Candiani

Funder

National Council for Scientific and Technological Development (CNPq)

São Paulo Research Foundation

Animal Toxins Research Support Center

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrinology,Physiology,Biochemistry

Reference44 articles.

1. Peptidomics of three Bothrops snake venoms: insights into the molecular diversification of proteomes and peptidomes;Tashima;Mol. Cell. Proteomics,2012

2. Analysis of the ontogenetic variation in the venom proteome/peptidome of Bothrops jararaca reveals different strategies to deal with prey;Zelanis;J. Proteome Res.,2010

3. Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise;Slagboom;Br. J. Haematol.,2017